Bernd Bohr
2 Papers
Bernd Bohr is an academic researcher. The author has contributed to research in topics: Translocator protein & Neurodegeneration. The author has co-authored 1 publications.
Chat about Author
Papers
[18F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data
Annamaria Ballweg,Carolin Klaus,Letizia Vogler,Sabrina Katzdobler,Karin Wind,A.V Zatcepin,Sibylle Ziegler,Birkan Secgin,Florian Eckenweber,Bernd Bohr,Alexander M. Bernhardt,Urban M. Fietzek,Boris-Stephan Rauchmann,Sophia Stoecklein,S. Quach,Leonie Beyer,Maximilian Scheifele,Marcel Simmet,Emanuel Joseph,Simon Lindner,I. Berg,Norman Koglin,Andre Mueller,Andrew W. Stephens,Peter Bartenstein,Jörg C. Tonn,Nathalie L. Albert,Tania Kümpfel,Martin Kerschensteiner,Robert Perneczky,Johannes Levin,Lars Paeger,Jochen Herms,Matthias Brendel +33 more
TL;DR: In this article , the capability of a novel monoamine oxidase B (MAO-B) PET ligand to monitor reactive gliosis in a transgenic mouse model of Alzheimer's disease (AD) was investigated.
Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [18F]UCB-H PET imaging
Letizia Vogler,Annamaria Ballweg,Bernd Bohr,Nils Briel,Karin Wind,M. Antons,L. Kunze,Johannes Gnörich,Simon Lindner,Franz Josef Gildehaus,Karlheinz Baumann,Peter Bartenstein,Guido Boening,Sibylle Ziegler,Johannes Levin,Andreas Zwergal,Günter U. Höglinger,Jochen Herms,Matthias Brendel +18 more
- 01 Jul 2023
TL;DR: Highlights • [18F]UCB-H was evaluated as a preclinical biomarker of synapse density in Alzheimer’s disease (AD) models and may be a more reliable surrogate of neurodegeneration than glucose metabolism in AD models.